Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 347

1.

The Impact of Grantsmanship Self-Efficacy on Early Stage Investigators of The National Research Mentoring Network Steps Toward Academic Research (NRMN STAR).

Thorpe RJ Jr, Vishwanatha JK, Harwood EM, Krug EL, Unold T, Boman KE, Jones HP.

Ethn Dis. 2020 Jan 16;30(1):75-82. doi: 10.18865/ed.30.1.75. eCollection 2020 Winter.

PMID:
31969786
2.

Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens.

Wahlin S, Nodin B, Leandersson K, Boman K, Jirström K.

Oncoimmunology. 2019 Aug 3;8(11):e1644108. doi: 10.1080/2162402X.2019.1644108. eCollection 2019.

3.

Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis.

Greve AM, Bang CN, Boman K, Egstrup K, Kesäniemi YA, Ray S, Pedersen TR, Wachtell K.

Am J Cardiol. 2019 Dec 1;124(11):1736-1740. doi: 10.1016/j.amjcard.2019.08.037. Epub 2019 Sep 7.

PMID:
31586530
4.

Flawed conclusions on the Västerbotten Intervention Program by San Sebastian et .al.

Blomstedt Y, Norberg M, Ng N, Nyström L, Boman K, Lönnberg G, Stenlund H, Wall S, Weinehall L.

BMC Public Health. 2019 Aug 13;19(1):1095. doi: 10.1186/s12889-019-7444-3.

5.

Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden.

Lindmark K, Boman K, Olofsson M, Törnblom M, Levine A, Castelo-Branco A, Schlienger R, Bruce Wirta S, Stålhammar J, Wikström G.

Clin Epidemiol. 2019 Mar 22;11:231-244. doi: 10.2147/CLEP.S170873. eCollection 2019.

6.

Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trial.

Wang A, Arver S, Boman K, Gerstein HC, Fu Lee S, Hess S, Rydén L, Mellbin LG.

Eur J Prev Cardiol. 2019 May;26(8):847-854. doi: 10.1177/2047487318819142. Epub 2018 Dec 19.

PMID:
30567457
7.

Long-term health-related quality of life in children with lymphatic malformations treated with sclerotherapy generally matched age-appropriate standardised population norms.

Ghaffarpour N, Claesson G, Wester T, Boman KK.

Acta Paediatr. 2019 Aug;108(8):1499-1506. doi: 10.1111/apa.14700. Epub 2019 Mar 24.

PMID:
30556934
8.

Effect of simvastatin and ezetimibe on suPAR levels and outcomes.

Hodges GW, Bang CN, Forman JL, Olsen MH, Boman K, Ray S, Kesäniemi YA, Eugen-Olsen J, Greve AM, Jeppesen JL, Wachtell K.

Atherosclerosis. 2018 May;272:129-136. doi: 10.1016/j.atherosclerosis.2018.03.030. Epub 2018 Mar 16.

PMID:
29602140
9.

A mixed methods study of Tai Chi exercise for patients with chronic heart failure aged 70 years and older.

Hägglund L, Boman K, Brännström M.

Nurs Open. 2018 Feb 21;5(2):176-185. doi: 10.1002/nop2.127. eCollection 2018 Apr.

10.

SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis.

Hodges GW, Bang CN, Eugen-Olsen J, Olsen MH, Boman K, Ray S, Kesäniemi AY, Jeppesen JL, Wachtell K.

Open Heart. 2018 Jan 13;5(1):e000743. doi: 10.1136/openhrt-2017-000743. eCollection 2018.

11.

Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study).

Greve AM, Bang CN, Boman K, Egstrup K, Forman JL, Kesäniemi YA, Ray S, Pedersen TR, Best P, Rajamannan NM, Wachtell K.

Am J Cardiol. 2018 Mar 15;121(6):739-745. doi: 10.1016/j.amjcard.2017.12.011. Epub 2017 Dec 25.

PMID:
29361285
12.

NTproBNP and ST2 as predictors for all-cause and cardiovascular mortality in elderly patients with symptoms suggestive for heart failure.

Boman K, Thormark Fröst F, Bergman AR, Olofsson M.

Biomarkers. 2018 May - Jun;23(4):373-379. doi: 10.1080/1354750X.2018.1431692. Epub 2018 Feb 6.

PMID:
29355441
13.

Information needs of survivors and families after childhood CNS tumor treatment: a population-based study.

Hovén E, Lannering B, Gustafsson G, Boman KK.

Acta Oncol. 2018 May;57(5):649-657. doi: 10.1080/0284186X.2017.1406136. Epub 2017 Dec 1.

PMID:
29191069
14.

Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events.

Bang CN, Greve AM, Rossebø AB, Ray S, Egstrup K, Boman K, Nienaber C, Okin PM, Devereux RB, Wachtell K.

J Am Heart Assoc. 2017 Nov 27;6(12). pii: e006709. doi: 10.1161/JAHA.117.006709.

15.

Symptom Relief and Palliative Care during the Last Week of Life among Patients with Heart Failure: A National Register Study.

Årestedt K, Alvariza A, Boman K, Öhlén J, Goliath I, Håkanson C, Fürst CJ, Brännström M.

J Palliat Med. 2018 Mar;21(3):361-367. doi: 10.1089/jpm.2017.0125. Epub 2017 Oct 19.

PMID:
29048982
16.

Anaemia, but not iron deficiency, is associated with clinical symptoms and quality of life in patients with severe heart failure and palliative home care: A substudy of the PREFER trial.

Boman K, Olofsson M, Bergman AR, Brännström M.

Eur J Intern Med. 2017 Dec;46:35-40. doi: 10.1016/j.ejim.2017.08.027. Epub 2017 Sep 9.

PMID:
28899603
17.

Patients' experiences of person-centred integrated heart failure care and palliative care at home: an interview study.

Talabani N, Ängerud KH, Boman K, Brännström M.

BMJ Support Palliat Care. 2017 Jul 7. pii: bmjspcare-2016-001226. doi: 10.1136/bmjspcare-2016-001226. [Epub ahead of print]

PMID:
28689185
18.

Areas for quality improvements in heart failure care: quality of care from the family members' perspective.

Ängerud KH, Boman K, Brännström M.

Scand J Caring Sci. 2018 Mar;32(1):346-353. doi: 10.1111/scs.12468. Epub 2017 May 24.

PMID:
28543624
19.

Family members' experiences of integrated palliative advanced home and heart failure care: A qualitative study of the PREFER intervention.

Alvariza A, Årestedt K, Boman K, Brännström M.

Palliat Support Care. 2018 Jun;16(3):278-285. doi: 10.1017/S1478951517000256. Epub 2017 May 3.

PMID:
28464977
20.

Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis.

Lønnebakken MT, De Simone G, Saeed S, Boman K, Rossebø AB, Bahlmann E, Gohlke-Bärwolf C, Gerdts E.

Heart. 2017 Sep;103(18):1443-1448. doi: 10.1136/heartjnl-2016-310917. Epub 2017 Apr 28.

PMID:
28455295
21.

The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.

Rautio A, Boman K, Gerstein HC, Hernestål-Boman J, Lee SF, Olofsson M, Mellbin LG.

Diab Vasc Dis Res. 2017 Jul;14(4):345-352. doi: 10.1177/1479164117703034. Epub 2017 Apr 12.

PMID:
28403644
22.

Longitudinal 10-year changes in dietary intake and associations with cardio-metabolic risk factors in the Northern Sweden Health and Disease Study.

Winkvist A, Klingberg S, Nilsson LM, Wennberg M, Renström F, Hallmans G, Boman K, Johansson I.

Nutr J. 2017 Mar 28;16(1):20. doi: 10.1186/s12937-017-0241-x.

23.

Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.

Boman K, Andersson G, Wennersten C, Nodin B, Ahlgren G, Jirström K.

Biomark Res. 2017 Mar 14;5:10. doi: 10.1186/s40364-017-0090-y. eCollection 2017.

24.

The impact of time to heart failure diagnosis on outcomes in patients tailored for heart failure treatment by use of natriuretic peptides. Results from the UPSTEP study.

Karlström P, Johansson P, Dahlström U, Boman K, Alehagen U.

Int J Cardiol. 2017 Jun 1;236:315-320. doi: 10.1016/j.ijcard.2017.02.054. Epub 2017 Feb 17.

PMID:
28268084
25.

Comparison of Frequency of Ischemic Cardiovascular Events in Patients With Aortic Stenosis With Versus Without Asymmetric Septal Hypertrophy (from the SEAS Trial).

Einarsen E, Cramariuc D, Lønnebakken MT, Boman K, Gohlke-Bärwolf C, Chambers JB, Gerdts E.

Am J Cardiol. 2017 Apr 1;119(7):1082-1087. doi: 10.1016/j.amjcard.2016.11.064. Epub 2017 Jan 6.

PMID:
28132685
26.

A client-centred programme focusing energy conservation for people with heart failure.

Norberg EB, Löfgren B, Boman K, Wennberg P, Brännström M.

Scand J Occup Ther. 2017 Nov;24(6):455-467. doi: 10.1080/11038128.2016.1272631. Epub 2017 Jan 5.

PMID:
28052703
27.

Areas for quality improvements in heart failure care: quality of care from the patient's perspective.

Ängerud KH, Boman K, Ekman I, Brännström M.

Scand J Caring Sci. 2017 Dec;31(4):830-838. doi: 10.1111/scs.12404. Epub 2016 Nov 18.

PMID:
27859523
28.

Decreasing prevalence of abdominal aortic aneurysm and changes in cardiovascular risk factors.

Persson SE, Boman K, Wanhainen A, Carlberg B, Arnerlöv C.

J Vasc Surg. 2017 Mar;65(3):651-658. doi: 10.1016/j.jvs.2016.08.091. Epub 2016 Oct 25.

29.

Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study.

Mancusi C, Gerdts E, de Simone G, Midtbø H, Lønnebakken MT, Boman K, Wachtell K, Dahlöf B, Devereux RB.

Blood Press. 2017 Jun;26(3):150-155. doi: 10.1080/08037051.2016.1243009. Epub 2016 Nov 24.

PMID:
27710139
30.

SuPAR Predicts Cardiovascular Events and Mortality in Patients With Asymptomatic Aortic Stenosis.

Hodges GW, Bang CN, Eugen-Olsen J, Olsen MH, Boman K, Ray S, Gohlke-Bärwolf C, Kesäniemi YA, Jeppesen JL, Wachtell K.

Can J Cardiol. 2016 Dec;32(12):1462-1469. doi: 10.1016/j.cjca.2016.04.012. Epub 2016 May 3.

PMID:
27499378
31.

Changes in Dietary Fat Intake and Projections for Coronary Heart Disease Mortality in Sweden: A Simulation Study.

Björck L, Rosengren A, Winkvist A, Capewell S, Adiels M, Bandosz P, Critchley J, Boman K, Guzman-Castillo M, O'Flaherty M, Johansson I.

PLoS One. 2016 Aug 4;11(8):e0160474. doi: 10.1371/journal.pone.0160474. eCollection 2016.

32.

Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).

Nielsen OW, Sajadieh A, Sabbah M, Greve AM, Olsen MH, Boman K, Nienaber CA, Kesäniemi YA, Pedersen TR, Willenheimer R, Wachtell K.

Circulation. 2016 Aug 9;134(6):455-68. doi: 10.1161/CIRCULATIONAHA.115.021213. Epub 2016 Aug 2.

PMID:
27486164
33.

Increased hsCRP is associated with higher risk of aortic valve replacement in patients with aortic stenosis.

Blyme A, Asferg C, Nielsen OW, Boman K, Gohlke-Bärwolf C, Wachtell K, Olsen MH.

Scand Cardiovasc J. 2016 Jun;50(3):138-45. doi: 10.3109/14017431.2016.1151928. Epub 2016 Mar 8.

PMID:
26911132
34.
35.

Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.

Rautio A, Boman K, Eriksson JW, Svensson MK.

Diab Vasc Dis Res. 2016 May;13(3):183-91. doi: 10.1177/1479164115618516. Epub 2016 Jan 27.

PMID:
26818227
36.

Impacts of person-centred integrated chronic heart failure and palliative home care on pharmacological heart failure treatment: a substudy of a randomised trial.

Markgren R, Brännström M, Lundgren C, Boman K.

BMJ Support Palliat Care. 2019 Mar;9(1):e10. doi: 10.1136/bmjspcare-2015-000894. Epub 2016 Jan 20.

PMID:
26792391
37.

Impact of a combined community and primary care prevention strategy on all-cause and cardiovascular mortality: a cohort analysis based on 1 million person-years of follow-up in Västerbotten County, Sweden, during 1990-2006.

Blomstedt Y, Norberg M, Stenlund H, Nyström L, Lönnberg G, Boman K, Wall S, Weinehall L.

BMJ Open. 2015 Dec 18;5(12):e009651. doi: 10.1136/bmjopen-2015-009651.

38.

A cost-effectiveness study of person-centered integrated heart failure and palliative home care: Based on a randomized controlled trial.

Sahlen KG, Boman K, Brännström M.

Palliat Med. 2016 Mar;30(3):296-302. doi: 10.1177/0269216315618544. Epub 2015 Nov 24.

PMID:
26603186
39.

Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).

Bang CN, Greve AM, La Cour M, Boman K, Gohlke-Bärwolf C, Ray S, Pedersen T, Rossebø A, Okin PM, Devereux RB, Wachtell K.

Am J Cardiol. 2015 Dec 15;116(12):1840-4. doi: 10.1016/j.amjcard.2015.09.026. Epub 2015 Oct 3.

PMID:
26602073
40.

Left Ventricular Wall Stress-Mass-Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE Study.

Devereux RB, Bang CN, Roman MJ, Palmieri V, Boman K, Gerdts E, Nieminen MS, Papademetriou V, Wachtell K, Hille DA, Dahlöf B.

Hypertension. 2015 Nov;66(5):945-53. doi: 10.1161/HYPERTENSIONAHA.114.05582. Epub 2015 Sep 21.

PMID:
26418019
41.

Responder to BNP-guided treatment in heart failure. The process of defining a responder.

Karlström P, Dahlström U, Boman K, Alehagen U.

Scand Cardiovasc J. 2015;49(6):316-24. doi: 10.3109/14017431.2015.1070961. Epub 2015 Sep 23.

PMID:
26153427
42.

Patients with lymphatic malformations who receive the immunostimulant OK-432 experience excellent long-term outcomes.

Ghaffarpour N, Petrini B, Svensson LA, Boman K, Wester T, Claesson G.

Acta Paediatr. 2015 Nov;104(11):1169-73. doi: 10.1111/apa.13086. Epub 2015 Jul 14.

PMID:
26081020
43.

Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.

Okin PM, Hille DA, Wachtell K, Kjeldsen SE, Boman K, Dahlöf B, Devereux RB.

J Hypertens. 2015 Jul;33(7):1480-6. doi: 10.1097/HJH.0000000000000559.

PMID:
25799208
44.

High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy.

Blyme A, Asferg C, Nielsen OW, Sehestedt T, Kesäniemi YA, Gohlke-Bärwolf C, Boman K, Willenheimer R, Ray S, Nienaber CA, Rossebø A, Wachtell K, Olsen MH.

Open Heart. 2015 Feb 4;2(1):e000152. doi: 10.1136/openhrt-2014-000152. eCollection 2015.

45.

The prevalence and characteristics of pruritus in patients with heart failure.

Niklasson O, Boman K, Stenberg B.

Br J Dermatol. 2015 Jun;172(6):1541-1546. doi: 10.1111/bjd.13682. Epub 2015 May 12.

PMID:
25630690
46.

NT-proBNP predicts maintenance of sinus rhythm after electrical cardioversion.

Andersson J, Rosenqvist M, Tornvall P, Boman K.

Thromb Res. 2015 Feb;135(2):289-91. doi: 10.1016/j.thromres.2014.11.014. Epub 2014 Nov 20.

PMID:
25481046
47.

Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.

Greve AM, Bang CN, Berg RM, Egstrup K, Rossebø AB, Boman K, Nienaber CA, Ray S, Gohlke-Baerwolf C, Nielsen OW, Okin PM, Devereux RB, Køber L, Wachtell K.

Int J Cardiol. 2015 Feb 1;180:122-8. doi: 10.1016/j.ijcard.2014.11.181. Epub 2014 Nov 26.

PMID:
25438232
48.

Altered self-perception in adult survivors treated for a CNS tumor in childhood or adolescence: population-based outcomes compared with the general population.

Hörnquist L, Rickardsson J, Lannering B, Gustafsson G, Boman KK.

Neuro Oncol. 2015 May;17(5):733-40. doi: 10.1093/neuonc/nou289. Epub 2014 Oct 20.

49.

Sex differences in cardiovascular outcome during progression of aortic valve stenosis.

Cramariuc D, Rogge BP, Lønnebakken MT, Boman K, Bahlmann E, Gohlke-Bärwolf C, Chambers JB, Pedersen TR, Gerdts E.

Heart. 2015 Feb;101(3):209-14. doi: 10.1136/heartjnl-2014-306078. Epub 2014 Oct 9.

50.

Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.

Wennersten C, Andersson G, Boman K, Nodin B, Gaber A, Jirström K.

Diagn Pathol. 2014 Oct 3;9:189. doi: 10.1186/s13000-014-0189-5.

Supplemental Content

Support Center